Case Discussions in Interventional Glaucoma: Best Practices for Using Implants and MIGS (CME Webcast)

Activity Description and Purpose

The glaucoma treatment paradigm of topical medical therapy as first-line treatment is being re-evaluated as interventional approaches increase options for clinicians and patients. Sustained-release drug delivery (SRDD) and minimally invasive glaucoma surgery (MIGS) systems for glaucoma therapy are gaining ground as alternatives to self-administered topical therapy. This webcast features the proceedings of a live CME symposium held on Monday, October 21, 2024, in which program chair Joseph Panarelli, MD, and panelists Eileen Bowden, MD, and Arsham Sheybani, MD, discuss the latest in SRDD and MIGS in the treatment of patients with open-angle glaucoma. 

Target Audience

This educational activity is intended for ophthalmologists.

Learning Objectives

After completing this activity, participants will be better able to:

  • Demonstrate use of glaucoma sustained-release drug delivery devices for managing intraocular pressure in patient scenarios
  • Select appropriate minimally invasive glaucoma surgical devices to manage intraocular pressure in patient scenarios
  • Describe procedural techniques for minimally invasive glaucoma surgical procedures that improve patient outcomes
Course summary
Available credit: 
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Participation
Course opens: 
12/20/2024
Course expires: 
12/31/2025

Faculty

Joseph F. Panarelli, MD (Chair)
Ellen J. Schapps Richman Professor of Ophthalmology
Department of Ophthalmology
Director, Division of Glaucoma Services
NYU Langone Eye Center
New York, New York

Eileen C. Bowden, MD
Assistant Professor of Ophthalmology
Associate Residency Program Director
Dell Medical School
University of Texas at Austin
Austin, Texas

Arsham Sheybani, MD
Associate Professor of Ophthalmology
Residency Program Director, Ophthalmology
Washington University in St Louis
St Louis, Missouri

Disclosure Policy

MedEdicus adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been identified and mitigated by MedEdicus prior to the commencement of the activity.

Faculty

Eileen C. Bowden, MD, is an advisory board member of AbbVie Inc*.

Joseph F. Panarelli, MD, is a consultant for AbbVie Inc, Advanced Ophthalmic Innovations Pte Ltd, Alcon, CorneaGen, CorNeat Vision, Glaukos Corporation, New World Medical, Inc, Nova Eye Medical, Santen Inc, and Zeiss.

Arsham Sheybani, MD, is a consultant for AbbVie Inc, Alcon, Glaukos Corporation, and Nova Eye Medical.

Peer Reviewer

This activity was peer reviewed. The peer reviewer has no relevant commercial relationships to disclose.

Planners, Managers, and Writers

MedEdicus planners and managers have no relevant commercial relationships to disclose.

* The financial relationship existed during the past 24 months but has now ended

Accreditation Statement

MedEdicus LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

MedEdicus LLC designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Commercial Support

This continuing medical education activity is supported through an educational grant from AbbVie Inc.

Off-Label Discussion

This educational activity may include discussion of unlabeled and/or investigational uses of drugs and devices. Please refer to the official prescribing information for each drug or device discussed in this activity for approved dosing, indications, and warnings.

Provider Contact Information

For questions about this educational activity, please contact MedEdicus LLC at info@mededicus.com.

Disclaimer

The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of  MedEdicus LLC or AbbVie Inc.

This CME activity is copyrighted to MedEdicus LLC ©2024. All rights reserved. MedEdicus does not claim copyright to material included herein owned by third parties for which attribution or citation has been made. 333.2

Available Credit

  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Participation
Please login or register to take this course.

Clicking Register/Take course indicates that you have reviewed the CME information for this activity.